It looks like you're using an Ad Blocker.
Please white-list or disable AboveTopSecret.com in your ad-blocking tool.
Thank you.
Some features of ATS will be disabled while you continue to use an ad-blocker.
(Reuters) - The U.S. health regulator approved GW Pharmaceuticals Plc’s epilepsy treatment on Monday, making it the first cannabis-based drug to win approval in the country and opening floodgates for more research into the medicinal properties of cannabis.
The drug’s approval permits its use in patients aged two years and older with Dravet Syndrome (DS) and Lennox-Gastaut Syndrome (LGS), rare childhood-onset forms of epilepsy that are among the most resistant to treatment.
“This approval serves as a reminder that advancing sound development programs that properly evaluate active ingredients contained in marijuana can lead to important medical therapies,” said Food and Drug Administration Commissioner Scott Gottlieb.
The drug, Epidiolex, is made up of cannabidiol (CBD), one of the hundreds of molecules found in the marijuana plant, and contains less than 0.1 percent of tetrahydrocannabinol (THC), the psychoactive component that makes people high.
originally posted by: LightSpeedDriver
a reply to: 727Sky
CBD oil is legal in the UK and the Netherlands (and I would guess much or most of the EU too) and has been for some time. It's nice to see the FDA free the way for big pharma to make money off a plant we should be allowed by default.
originally posted by: LightSpeedDriver
a reply to: BigDave-AR
My bad. I googled the product (Epidiolex) and it's just legal cbd. Nothing revolutionary or new or illegal before they produced their product. 0.1% THC. As close to zero as you can get almost.
ETA The terpenes, flavonoids and cryptoids are missing from the equation, regardless of the THC. This is why a complete plant extract is more desirable imho.